scholarly journals A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)

2014 ◽  
Vol 8 (1) ◽  
pp. 132-141 ◽  
Author(s):  
Vikas Pai ◽  
A Paneerselvam ◽  
Satinath Mukhopadhyay ◽  
Anil Bhansali ◽  
Dinesh Kamath ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document